Titan Biotech

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: INE150C01029
  • NSEID:
  • BSEID: 524717
INR
381.35
-19.3 (-4.82%)
BSENSE

Nov 20

BSE+NSE Vol: 1.06 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Titan Biotech
Bhansali Engg.
NOCIL
Nitta Gelatin
Vidhi Specialty
Oriental Aromat.
Rossari Biotech
DDev Plastiks
Jubilant Agri
S H Kelkar & Co.
Indokem
Why is Titan Biotech Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0.02 times
2
With a growth in Net Profit of 65.16%, the company declared Very Positive results in Sep 26
  • The company has declared positive results for the last 5 consecutive quarters
  • ROCE(HY) Highest at 23.79%
  • NET SALES(Q) Highest at Rs 76.46 cr
  • PBDIT(Q) Highest at Rs 15.01 cr.
3
Stock is technically in a Bullish range
  • The technical trend has improved from Mildly Bullish on 06-Nov-26 and has generated 9.69% returns since then
  • Multiple factors for the stock are Bullish like MACD, Bollinger Band and KST
4
Consistent Returns over the last 3 years
  • Along with generating 150.49% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to Titan Biotech should be less than 10%
  2. Overall Portfolio exposure to Specialty Chemicals should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Titan Biotech for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Titan Biotech
150.49%
1.49
101.16%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
9.59%
EBIT Growth (5y)
1.64%
EBIT to Interest (avg)
29.57
Debt to EBITDA (avg)
0.20
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
1.17
Tax Ratio
27.70%
Dividend Payout Ratio
7.68%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
21.81%
ROE (avg)
18.80%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
51
Industry P/E
37
Price to Book Value
9.71
EV to EBIT
46.07
EV to EBITDA
41.02
EV to Capital Employed
9.66
EV to Sales
8.18
PEG Ratio
0.75
Dividend Yield
0.10%
ROCE (Latest)
20.96%
ROE (Latest)
19.06%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

24What is working for the Company
ROCE(HY)

Highest at 23.79%

NET SALES(Q)

Highest at Rs 76.46 cr

PBDIT(Q)

Highest at Rs 15.01 cr.

PBT LESS OI(Q)

Highest at Rs 13.41 cr.

PAT(Q)

Highest at Rs 12.55 cr.

EPS(Q)

Highest at Rs 2.43

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Titan Biotech
Net Sales - Quarterly
At Rs 76.46 cr has Grown at 40.68%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 13.41 cr has Grown at 69.75%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 12.55 cr has Grown at 61.7%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 76.46 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 15.01 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 13.41 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 12.55 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 2.43
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)